Pfizer vaccine still effective for new variants, says BioNTech head
Share article:
Share article:

Pfizer vaccine still effective for new variants, says BioNTech head

Credit: Lisa Ferdinando/ cc-by-2.0

The Pfizer/BioNTech vaccine does not “yet” need to be adapted to deal with the new variants of the coronavirus in circulation, the head of BioNTech assured a press conference on Monday, advocating instead a third “booster” dose.

“It is quite possible that in the next six to 12 months, further variants will emerge and that would require adaptation of the vaccine but it is at the moment not yet the case,” said Ugur Sahin.

“Making a decision at the moment might turn out to be wrong in three or six months if another variant is dominating. Therefore the timing of the decision must be appropriate,” he said.

“At the moment we have a good understanding that the booster vaccine with the parental strain is completely sufficient,” he added.

The headquarters of Pfizer in the US did not reply to a request last week from The Brussels Times to comment on the need and timing of booster campaigns. Besides Israel, other countries, including EU member states, have started or are planning such campaigns for a third vaccine shot starting in September.

Made in Belgium

More than 100 million doses of the vaccine leave the production site in Antwerp, Puurs-Sint-Amands, every month, to be shipped to other countries in the EU and further abroad.

Especially in the first four months of this year, Pfizer played a big role in the export of vaccines from Belgium, which exported coronavirus vaccines worth €3.8 billion, of which Pfizer reported sales of its vaccines equivalent to €2.9 billion.

Related News


The EU’s joint vaccine procurement programme provided 330 million doses of BioNTech-Pfizer vaccine, 100 million of AstraZeneca, 50 million of Moderna and 20 million of Johnson & Johnson, whilst in May, the EU signed a new contract to buy up to 1.8 billion doses of vaccine from BioNTech-Pfizer for delivery until 2023.

Pfizer forecast it would sell around €21.91 billion worth of coronavirus vaccines by the end of July, however, this has increased to €28.23 billion worth of vaccines. In May, Moderna was expecting annual sales of around €16.43 billion.

Latest news

Duvel celebrates 150th anniversary with special brew in commemorative bottle
Belgium’s Duvel Moortgat Brewery is celebrating its 150th anniversary with the release of a special brew in a commemorative bottle shaped like its ...
Pollution scandal: 3M to show emissions don’t pose risk or halt production
Flanders has ordered American company 3M, involved in a pollution scandal in Antwerp, to prove that emissions linked to its production activities do ...
The Netherlands fears a greater rise in sea levels than forecast
Sea levels could rise by up to two metres by 2100 on the Dutch coastline – far more than previously forecast – according to an announcement from the ...
The Smurfs return to Belgian TV with the first new show since 1989
A new Smurfs show is bringing the characters of Belgium's second-most-famous comic franchise back to the small screen with their first new series, 30 ...
Almost half of Belgian subsidies from EU left unused
Belgium left almost half (49%) of its subsidies allocated by the European Union between 2013 and 2020 unused, the equivalent of around €1.375 ...
Visitors to embark on Orient Express adventure at Brussels exhibition
An exhibition dedicated to the Orient Express – the train that was the scene for many novels, including Agatha Christie's – allows visitors to ...
Offers for fake Covid Safe Tickets circulating on social media
As the Covid Safe Ticket (CST) becomes mandatory in many places across Belgium, offers for forgeries are increasingly circulating on social media. ...
Belgium in Brief: Feeling Good/ Pandemic Law
Yesterday I said I was writing a newsletter I didn't want to write again. Today I'm writing another one ahead of a meeting that wasn't supposed ...
Eating less meat won’t actually help much with Flemish CO2 emissions
When it comes to the ways in which ordinary people can help to reduce CO2 emissions, eating less meat is often touted as an important solution. ...
At least one in seven coronavirus patients suffers from long-term Covid
Six months after becoming infected with the coronavirus, at least one in seven people still show symptoms connected to the infection, varying from ...
Operation Sky ECC: Major arrests and another large scale operation
A major operation took place last night in Belgium as a result of Operation Sky ECC, the name given to an investigation into organised crime that ...
On this day in Brussels: An entrepreneurial journey begins
The Rue Dansaert was just beginning to become trendy when Alain Coumont opened his first bakery here on 26 October 1990. He started by baking big ...